Intravenous (IV) therapy devices are used to administer liquid substances directly into a vein. They can deliver nutrients or medications such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. These devices offer significant advantages over manual fluid administration, including the ability to deliver fluids in very small volumes and at precisely programmed rates or automated intervals. These devices are also used for blood transfusion.

The IV Equipment Market competitive landscape includes the analysis of key growth and business strategies adopted by major players to expand their presence and increase their shares in the global market.

These are the leading players in the IV equipment market, and are recognized as Visionary companies. They have strong product portfolios and robust business strategies to achieve continued growth.

These companies have strong business strategies and has the potential to broaden its product portfolios to compete with other key market players.

They have innovative products and the potential to build strong strategies for business growth to be at par with the Vanguards.

They have the potential to build strong product portfolios and business strategy to compete in the market with Vanguards and Innovators. The home care segment accounted for major a share of the global IV equipment market. The growth of this segment is mainly driven by technological advancements in IV equipment, rapid growth in the elderly population, and increased government pressure to reduce hospital stays and related healthcare expenditures. Technological advancements in IV therapy have enabled the development of compact and lightweight devices that are safe to administer and easy to carry and operate. IV pumps or infusion pumps used in home care are usually smaller, lighter, and easier to transport. These devices are used in the treatment of many chronic diseases such as cancer, diabetes, and cardiovascular diseases. IV therapy is also used to provide nutritional support services like total parenteral nutrition (TPN) even after hospital discharge. Ambulatory infusion pumps for chronic disease management enable patients to be mobile during therapy sessions and helps patients reduce their hospital stay. Moreover, these devices are inexpensive and easy to use, enhance patient compliance for treatment, and reduce the cost of hospitalization. Ambulatory care centers (ACCs) include hospice care organizations, assisted living facilities, ambulatory surgical centers (ASCs), and nursing homes. Due to persistent cost pressures in the hospital segment, there has been a shift from extended hospital treatment towards a treatment at ambulatory care organizations. Physicians also support the development of new ambulatory surgical centers as they gain better control over their surgical practices by operating in an ASC instead of the hospital. In the ASC setting, physicians can schedule procedures more conveniently, assemble teams of specially trained and highly skilled staff, ensure that the equipment and supplies being used are best suited to their techniques, and design facilities tailored to their specialties as well as the specific needs of their patients.